Table of Contents Table of Contents
Previous Page  855 / 1096 Next Page
Information
Show Menu
Previous Page 855 / 1096 Next Page
Page Background

S839

ESTRO 36

_______________________________________________________________________________________________

Conclusion

Using a minimum dose concept for dose painting with only

an overall maximum constraint gives more robust plans

than a voxel-by-voxel exact dose prescription, while

maintaining maximum dose constraints. Highest

adherence to dose painting degree of heterogeneity could

be obtained with the minimum-map approach.

EP-1558 Dosimetric evaluation of incidental radiation

of internal mammary chain in breast cancer with 3D RT

A.C. Ciafre

1

, J. Castilla

1

, C. Domingo

1

, E. Jorda

1

, D.

Dualde

1

, E. Ferrer

1

1

Hospital Clinico Universitario, Oncologia Radioterapica,

Valencia, Spain

Purpose or Objective

The internal mammary chain represents a less common yet

important rout of lymphatic drainage of breast cancer,

constituting a matter of debate in the current clinical

practice. Poortmans P. 2015 suggests an improvement of

disease-free survival, distant disease-free survival and a

reduction of breast cancer mortality when they included

the internal mammary and medial supraclavicular lymph-

node irradiation. This study intends to determinate the

incidental coverage and dose distribution of the internal

mammary chain in breast cancer treatment, using

tangential and opposite fields with 3D External

Radiotherapy.

Material and Methods

We randomly reviewed 47 female patients treated at one

institution between January and December of 2013 with

an average age of 62 years. Thirty seven patients (78%)

had invasive ductal carcinoma (IDC), and 10 patients

(21.2%) other histology types; Her2: Negative (82%),

hormonal receptors were positive in all of them, 30

affecting the left and 17 the right breast. The majority of

tumours were <2cm (n:41/47). Lumpectomy + Sentinel

node biopsy (SLN) was performed in 36 patients, one of

them with posterior axillary lymph node dissection due to

positivity of SNL and the remaining patients were

candidates for axillary lymph node dissection. External

radiotherapy was administrated exclusively on the breast

with tangential and opposite fields with total dose: 50Gy

in 5 weeks with 5 fractions per week (200cGy per

fraction). Once the treatment was completed, we contour

the internal mammary chain according to the Breast Atlas

for radiation therapy planning consensus definitions of the

RTOG.

Results

With an average volume of the internal mammary chain of

4.13 cm3, the median minimal dose and maximal dose

delivered was 278cGy and 4008cGy respectively, this last

one corresponding to 8% of Total dose prescribed for the

mammary gland. The median V95 was 297.04cGy.

Conclusion

The radiation of the internal mammary chain on patients

of this study have showed minimal incidental doses,

therefore we concluded that the contouring, volume

delimitation and dose prescription has been appropriated

by not affecting unwanted areas. In the other hand

unintended radiation of internal mammary chain turns out

as insufficient to treat subclinical disease.

EP-1559 Optimizing the risks for deterministic effects

and secondary malignancies in bladder and rectum

G. Komisopoulos

1

, C. Buckey

2

, S. Stathakis

3

, M.

Mavroeidi

4

, G.P. Swanson

5

, D. Baltas

6

, N. Papanikolaou

3

,

P. Mavroidis

4

1

University Hospital of Larissa and General Hospital of

Larissa- Greece, Medical Physics, Larissa, Greece

2

Mayo Clinic- AZ, Radiation Oncology, Scottsdale, USA

3

University of Texas Health Sciences Center at San

Antonio, Radiation Oncology, San Antonio- TX, USA

4

University of North Carolina, Radiation Oncology,

Chapel Hill, USA

5

Baylor Scott & White Healthcare Temple Clinic,

Radiation Oncology, Temple- TX, USA

6

University of Freiburg & German Cancer Consortium

DKTK- Partner Site, Radiation Oncology-, Freiburg,

Germany

Purpose or Objective

To use radiobiological metrics to estimate the

effectiveness of IMRT and Conformal Radiation Therapy

(CRT) modalities in treating prostate tumors. Additionally,

to estimate the risk of secondary malignancies in bladder

and rectum due to radiotherapy from these treatment

modalities.

Material and Methods

For ten prostate cancer patients, IMRT and CRT plans were

developed. For the IMRT plans, two beam energies (6 and

18 MV) and two treatment protocols were used (RTOG

0415 and FCCC). For the evaluation of the deterministic

effects of these plans, the tumor control probabilities

(TCP) and normal tissues complication probabilities

(NTCP) were calculated using the LQ-Poisson and Relative

Seriality models. Additionally, the complication-free

tumor control probability and the biologically effective

uniform dose were calculated for each plan. The risks for

secondary malignancies were calculated for bladder and

rectum for the different treatment modalities using the

LQ model proposed by UNSCEAR.

Results

The deterministic response probabilities of bladder were

lower than those of rectum in all the plans. For bladder,

the highest value was for the IMRT FCCC-18X (0.03%) and

the lowest for the CRT-18X modality (0.0%). For rectum,

the highest value was for the IMRT RTOG-6X (3.52%) and

the lowest for the IMRT FCCC-18X modality (0.41%).

The average risk for secondary malignancy was lower for

bladder (0.37%) compared to rectum (0.81%) based on all

the treatment plans of the ten prostate cancer patients.

The highest average risk for secondary malignancy for

bladder and rectum was for the CRT-6X modality (0.46%

and 1.12%, respectively) and the lowest was for the IMRT

RTOG-18X modality (0.33% and 0.56%, respectively).

Fig. 1 shows the dose-responses of bladder and rectum for

a range of uniform doses for the different radiation

modalities. Additionally, the average response of each

modality is plotted accompanied by error bars indicating

the standard deviations of response and dose within the

patient group. In Fig. 2, the average distributions of the

risk for secondary malignancy in bladder (upper) and

rectum (lower) as a function of dose are presented for the

different modalities and protocols. The vertical lines

indicate the mean doses that are delivered to the bladder

and rectum by the examined treatment plans. The thick

solid line corresponds to uniform irradiation of the organ.

Conclusion

IMRT plans produced using the RTOG 0415 criteria had

equivalent dosimetric results with the CRT plans. General